ICD Co., Ltd.

ICD Co., Ltd.

KKRX:040910
3,780.00
KRW
+40.00
(+1.07%)
86.60EPS
57.25P/E
84.75BMarket Cap
Nov 12Next Earn
ICD Co., Ltd.
KRX:040910
(Korea Stock Exchange)

Recent

price

3,780.00

P/E

ratio

57.25

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
KRW
11,477.47
5,235.89
5,151.87
474.23
1,489.01
1,075.58
14,726.02
19,354.24
14,571.66
7,644.07
18,514.63
6,838.51
9,442.23
3,868.92
9,068.56
12,113.03
12,390.34
Revenue per Share
2,057.5
621
459
-699
-296
17
660.3
1,520
1,858
701
2,005
45
-339
-2,567
-1,738
-117
90.65
Basic EPS, GAAP
-762.08
-878.83
925.55
103.81
-1,383.74
22.3
-2,261.89
-1,031.06
1,586.69
1,301.53
2,778.78
985.32
-1,512.36
-474.7
-1,912.17
438.59
1,653.4
Free Cash Flow per Basic Share
- -
- -
- -
- -
100.1
- -
- -
99.7
150.46
148.42
148.2
348.24
204.35
98.18
- -
- -
- -
Dividend per Share
5,783.87
6,289.36
6,654.17
5,847.25
5,479.95
5,657.14
7,014.66
8,328.47
8,347.7
8,919.35
10,655.15
10,289
9,697.59
7,849.88
5,945.71
6,033.5
5,812.08
Book Value per Share
5,393.21
5,840.07
5,785.73
5,066.95
4,230.79
4,442.71
5,158.21
6,699.89
7,115.93
7,784.43
9,690.64
9,663.16
9,161.9
7,492.57
5,699.06
5,843.6
5,633.03
Tangible Book Value per Share
12
16
16
16
16
16
16
16
16
16
17
17
16
16
16
16
16
Basic Weighted Avg Shares
143,149
81,237
81,040
7,561
23,887
16,863
230,909
311,848
233,975
121,605
308,965
115,769
150,945
62,274
147,616
197,041
202,029
Sales/Revenue/Turnover
22.74
16.05
11.17
-193.2
-29.31
6.7
6.99
11.83
16.97
11.76
16.21
1.48
-3.35
-63.12
-18.08
2.26
3.16
Operating Margin (%)
2,152
2,668
3,114
3,640
4,498
1,113
4,638
6,017
6,121
6,399
6,754
7,020
6,565
6,882
6,435
4,505
- -
Depreciation Expense
25,662
9,635
7,220
-11,144
-4,749
267
10,354
24,491
29,834
11,152
33,459
762
-5,419
-41,318
-28,291
-1,903
1,478
Net Income, GAAP
20.9
22.05
16.55
- -
- -
80.14
40.98
14.82
12.76
30.4
21.49
- -
- -
- -
- -
- -
2.52
Effective Tax Rate (%)
17.93
11.86
8.91
-147.4
-19.88
1.58
4.48
7.85
12.75
9.17
10.83
0.66
-3.59
-66.35
-19.17
-0.97
0.73
Profit Margin (%)
67,709
62,868
51,375
31,151
21,485
23,565
63,502
69,512
67,529
84,243
93,324
77,800
70,187
48,437
41,643
36,619
34,224
Working Capital
5,500
4,675
3,125
1,875
625
- -
28,347
9,053
6,059
5,278
4,302
3,456
2,670
2,108
1,132
314
326
LT Debt
89,706
97,609
105,421
93,898
88,036
90,882
112,691
134,140
131,399
147,055
179,474
167,937
153,246
127,183
97,012
98,477
94,861
Total Equity
40.68
9.85
7.06
- -
- -
0.24
7.43
17.81
19.11
5.93
21.27
- -
- -
- -
- -
- -
5.15
Return on Invested Capital (%)
43.9
9.89
6.94
- -
- -
0.29
8.43
15.41
18.17
7.31
18.72
- -
- -
- -
- -
- -
1.28
Return on Capital (%)
50.94
10.29
7.11
-11.18
-5.22
0.3
10.17
19.84
22.47
8.01
20.49
0.44
-3.37
-29.47
-25.24
-1.95
1.6
Return on Common Equity (%)

Capital Structure

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
20,603
18,520
18,533
LT Borrowings
125
- -
- -
LT Finance Leases
268
314
326
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
16
16
16
Market Capitalization
68,912
63,442
84,753

Working Capital

KRW

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
90,759
79,880
113,227
Cash, Cash Equivalents & STI
15,049
8,678
16,703
Accounts Receivable, Net
- -
24,234
- -
Inventories
46,301
30,641
43,227
Total Current Liabilities
56,394
43,261
79,004
Payables & Accruals
- -
- -
- -
ST Debt
20,603
18,520
18,533
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.06%
-10.88%
1.51%
Free Cash Flow
-1,064.09%
-38.58%
-122.92%
Net Income, GAAP
370.91%
-74.29%
-93.27%
Sales/Revenue/Turnover
146.51%
15.93%
33.48%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
16,931
36,472
31,966
62,247
147,616
2025
17,452
85,735
41,891
51,963
197,041
2026
22,440
- -
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-316
-316
-60
-1,103.13
-1,738
2025
-425
6.85
15
287.02
-117
2026
-218.26
- -
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
ICD Co., Ltd. manufactures and sells semiconductor and flat panel display equipment primarily for AMOLED, LCD, LTPS-LCD, OTFT, and related applications; its core products include dry etchers, high density plasma (HDP) etchers, plasma ashers, plasma cleaners, research-thermal evaporators, electrostatic chucks (ESC), high voltage DC generators (HVDC), end point detection (EPD) systems, plasma coating components, surface treatment systems, and 3D glass forming equipment; it also develops plasma-based bio-medical products for sterilization, medicine, and cosmetics. The company operates in South Korea and exports internationally to serve display and semiconductor manufacturers. Founded in 2000 and headquartered in Anseong, South Korea, ICD focuses on plasma and vacuum technologies for precision etching and cleaning in semiconductor fabrication processes. In recent developments, ICD secured a 25 billion won order, reflecting strengthened demand in its core equipment segments.